funding is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Bharat Innovates 2026, the most common co-covered peer. Each carries 3 original sources on average. We currently track 1 Biotech story that mention Dharmendra Pradhan, all published on July 31, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Dharmendra Pradhan
funding is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Bharat Innovates 2026, the most common co-covered peer. Each carries 3 original sources on average. We currently track 1 Biotech story that mention Dharmendra Pradhan, all published on July 31, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 4 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Dharmendra Pradhan. Shared-story counts are live from our verified record — not editorial picks.
At Bharat Innovates 2026 in Nice, Union Minister Piyush Goyal committed the entire second edition of India's Startup Fund of Funds to deep tech, including medtech and healthcare. The move promises a major boost for Indian biotech startups, with 3,000 innovators invited to shape policy and access global markets through Free Trade Agreements. For biotech founders, this signals unprecedented government backing and a direct channel to influence the funding and regulatory landscape.
